Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Obstructive sleep apnea (typically causing hyperaldosteronism)
Drug-induced hypertension (especially nonsteroidal antiinflammatory drugs, steroids, and/or other immunosuppressants)
Thyroid disorders (hypothyroidism more commonly than hyperthyroidism)
Coarctation of the aorta (typically manifested as different blood pressures in the arms or a lower blood pressure in the legs)
Hyperparathyroidism (hypertension is found in only 10% of patients with hyperparathyroidism in the general population and up to 60% of those with additional endocrinopathies, especially multiple endocrine neoplasia syndrome. Removal of the parathyroid adenoma does not always lower blood pressure
Acromegaly (18% to 60% [increasing with age at diagnosis] of patients with acromegaly have hypertension; many have left ventricular hypertrophy; most respond well to antihypertensive drugs; and some have blood pressures that revert to normal when the acromegaly is cured)
“Neurogenic” hypertension
Liddle syndrome (a rare genetic disorder that is also called pseudohyperaldosteronism)
Most such patients are overweight or obese, and many have bed partners who note snoring and/or witness apneic episodes during sleep. The Berlin questionnaire may be useful in screening, but a polysomnographic sleep study is typically required for diagnosis. Cohort studies have shown a significant improvement in survival if continuous positive airway pressure (CPAP) is used during sleep; a meta-analysis of 18 randomized, clinical trials suggests that CPAP significantly lowers 24-hour ambulatory blood pressures (by about 2/2 mm Hg) but not cardiovascular events (odds ratio [OR] = 0.84, 95% confidence interval [CI]: 0.62 to 1.13) or death (OR = 0.85, 95% CI: 0.35 to 2.06). In patients with hyperaldosteronism and sleep apnea, CPAP is recommended primarily for its improvement in quality of life; blood pressure can typically be reduced even further by adding spironolactone or eplerenone; a serum aldosterone/renin ratio is often measured before starting such treatment.
Nonsteroidal antiinflammatory drugs (including agents that are more selective for the second isoform of cyclooxygenase, e.g., celecoxib) are probably the most common cause of drug-induced hypertension due to their widespread, unregulated use. The mechanism is not well worked out, although alteration in intrarenal prostaglandin metabolism, sodium retention, and edema formation is likely.
Anabolic steroids, glucocorticoids, and mineralocorticoids all raise blood pressure, and the usual recommendation is to use the lowest possible dose for the shortest possible time to decrease the risk of long-term consequences (including hypertension and its sequelae).
Patients with chronic kidney disease or transplant recipients often take drugs that raise blood pressure, including cyclosporine, erythropoietin, and tacrolimus. Elevated blood pressures after use of tyrosine kinase inhibitors (given for various cancers) are associated with a favorable tumor response. These drugs are so important for the patient’s overall health that they are continued, and more antihypertensive agents are added.
Many “street” drugs can raise blood pressure acutely; acute withdrawal from nicotine, heroin, or other opioids can have the same effect. The drugs most often causing hypertension in an Emergency Department setting are cocaine, methylphenidate (or other stimulants), gamma-hydroxybutyrate, ketamine, and ergotamine. Chronic ingestion of alcohol increases the risk of hypertension; a meta-analysis of 36 trials involving 2865 participants showed a dose-dependent, significant reduction in blood pressure (by 5.5/3.0 mm Hg, on average) in those who reduced their consumption from >2 drinks/day.
A large variety of other prescription drugs (e.g., phenylpropanolamines, oral contraceptive pills, venlafaxine) can raise blood pressure. A wide variety of other drugs can interfere with antihypertensive medications either directly or via inhibition of metabolic pathways (typically hepatic cytochrome P 450 or CYP oxidoreductases). Stimulants used in the treatment of ADHD can cause hypertension. methylphenidate, dextroamphetamine, and lisdexamfetamine can cause hypertension.
See Table 66.1 .
DRUGS THAT INDUCE HYPERTENSION | ANTIHYPERTENSIVE DRUG TREATMENT(S) |
---|---|
Corticosteroids, mineralocorticoids | Angiotensin-converting enzyme inhibitor, diuretic |
Nonsteroidal antiinflammatory drug | Diuretic, calcium antagonist, maybe alpha-1-blocker |
Phenylpropanolamine(s) | Beta-blocker |
Nasal decongestant(s) | Alpha-1-blocker or alpha-beta-blocker |
Cocaine | Alpha-blocker (typically phentolamine) |
Antidepressants (monoamine oxidase inhibitors, serotonin reuptake inhibitors, etc.) | Alpha-blocker, calcium antagonist (?) |
Oral contraceptive pills | None; stop oral contraceptive pills instead |
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here